Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Lantern Pharma has raised $4.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Lantern Pharma's investors include Bios Partners, Health Wildcatters, Green Park & Golf Ventures.
Lantern Pharma is headquartered in Dallas, United States.
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Lantern Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lantern Pharma — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/lantern-pharma. Accessed August 14, 2026.
VCBacked. (2026). Lantern Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lantern-pharma
{{cite web |title=Lantern Pharma — Funding & Investors |url=https://www.vcbacked.co/company/lantern-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated